Salvage Chemotherapy with Cisplatin and 5-Fluorouracil in Metastatic Breast Cancer-Particular Activity against Liver Metastases
Anticancer Research,  Clinical Article

Lekakis L et al. – The combination of cisplatin/5–fluorouracil (5–FU) is active and safe in heavily pre–treated patients with metastatic breast cancer even in the presence of liver metastases and jaundice.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Measuring the impact of the American College of Surgeons Oncology Group Z0011 trial on breast cancer surgery in a community health system The American Journal of Surgery, September 3, 2014    Clinical Article

2 Smartphone breast applications - What's the evidence? The Breast, September 9, 2014    Clinical Article

3 Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response The Lancet Oncology, September 2, 2014    Clinical Article

4 Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy Full Text Breast Cancer: Targets and Therapy, September 19, 2014    Free full text    Clinical Article

5 Adolescent meat intake and breast cancer risk International Journal of Cancer, September 17, 2014    Clinical Article

6 Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2–negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Journal of Clinical Oncology, September 22, 2014    Clinical Guideline

7 Attitudes toward molecular testing for personalized cancer therapy Cancer, September 26, 2014

8 Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy Medical Oncology, September 25, 2014    Clinical Article

9 The significance of circulating tumour cells in breast cancer: A review The Breast, September 3, 2014    Review Article

10 Pre-operative prognostic nutritional index predicts the outcomes for triple-negative breast cancer Tumor Biology, September 12, 2014    Review Article

11 PIK3CA mutations are associated with lower rates of pathologic complete response to anti–human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer Journal of Clinical Oncology, September 24, 2014    Clinical Article

12 Eribulin for the treatment of advanced or metastatic breast cancer: a NICE single technology appraisal PharmacoEconomics, September 15, 2014    Review Article

13 Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures Full Text World Journal of Surgical Oncology, August 4, 2014    Free full text    Clinical Article

14 Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy Tumor Biology, September 23, 2014    Clinical Article

15 Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011 JAMA, September 10, 2014    Clinical Article

16 Circulating tumor cells in non-metastatic triple-negative breast cancer Breast Cancer Research and Treatment, September 23, 2014    Clinical Article

17 Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer Annals of Surgical Oncology, September 23, 2014    Clinical Article

18 Genome-based risk prediction for early stage breast cancer Full Text The Oncologist, September 25, 2014    Free full text    Review Article

19 Factors influencing Oncotype DX use in the management of early breast cancer: A single centre experience European Journal of Cancer, September 2, 2014    Clinical Article

20 The impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemic Full Text Gland Surgery, September 2, 2014    Free full text    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close